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Abstract
Background: Pregnancy after kidney transplantation has been considered as high risk for maternal and fetal
complications. After careful patient selection successful pregnancies are described. Little is known about fetal
outcomes and data is particularly scarce on childrens´ early development up to two years when born to kidney/
−pancreas transplant recipients.
Here, we analyzed maternal and fetal risk and evaluated graft function during pregnancy in transplanted women.
We aimed to identify factors affecting the outcomes of mothers and their grafts during pregnancy and of children
up to 2 years after delivery/ birth.
Methods: All consecutive pregnancies in kidney/ kidney-pancreas recipients with live-born children from 2002 to
2016 were evaluated in two transplant centers (Charité Berlin/ University Tuebingen). All data was gathered from
medical records. Impact of pregnancy on obstetrical risks, graft function and fetal development was evaluated.
Additionally, for the first time development of children, including physical examination and assessment of
neurological function were evaluated at 12 and 24 months.
Results: Thirty-two pregnancies in 28 patients with a median duration of 34 gestational weeks (range, 24–38) were
analyzed. 13 patients (46.4%) developed deterioration of kidney graft function > 10 ml/min during pregnancy. In
majority, caesarean section was performed (75%). Twenty-five (78.1%) children were born prematurely, thereof (16%)
< 28 weeks. Almost 70% had low birth weights (LBW) (< 2.500 g); median birth weight was 2.030 g. General health
and physical constitution of children were unremarkable with normal development in 94% at 12 and 24 months of
corrected age, respectively.
Conclusion: Despite the high rate of preterm birth and LBW, development up to two years was age-appropriate in
this cohort. Due to low absolute numbers, increasing efforts in centralized counseling, diagnostics and committed
specialist support are required. Decisive treatment of these high-risk patients in specialized units leading to better
performance of these patients (mother/ fetus) is deemed superior. In order to confirm this, prospective studies on
neonatal and pediatric outcomes with a standard-of-care comparator arm will be conducted.
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Introduction
There is an increasing number of positive reports on
(successful) pregnancies in kidney transplant recipients
[1–5]. Nevertheless, pregnancies under these specific
conditions are considered as high risk especially con-
cerning unavoidable treatment of immunosuppressive
drugs, underlying kidney disease and other comorbidi-
ties. Indeed, complications are relatively common and
this should be reflected in patient counselling and clin-
ical decision making [6–8]. Among women after renal
transplantation the risk of pregnancy-related complica-
tions, including preeclampsia/ gestational diabetes, cae-
sarean section, prematurity, fetal growth restriction and
low birth weight compared to general population are sig-
nificantly increased in this subgroup [7, 9].
It was recently shown in a cohort of 56 female trans-
plant recipients that adequate graft function (creatinine
< 110 μmol/l) was positively correlated with pregnancy-
related complications such as preeclampsia and preterm
delivery [8].
Prematurity is associated with several acute and chronic
complications including respiratory distress syndrome,
intracranial hemorrhage, apnoea, retinopathy of prematur-
ity, seizures, necrotizing enterocolitis and temperature in-
stability [10]. These infants are at high risk of long-term
neurodevelopmental morbidities such as cerebral palsy,
mental disorders and impaired learning [11, 12].
Interestingly, data on children’s early development in
pregnancies after kidney transplantation are scarce even
though many reports on successful pregnancies in kid-
ney transplant recipients are available [3–8]. Even more,
mid- or long-term development and health of children
born to kidney transplanted mothers is a subject less
studied [13, 14]. The most recent analysis of children
born to transplanted mothers evaluated cognitive devel-
opment. Data suggest that their cognitive development
is no different from that of controls [15]. An earlier Na-
tional Transplant Pregnancy Registry analysis of children
exposed in utero to cyclosporine, revealed no increased
risk of birth defects, significant problems with renal
function, attention-deficit hyperactivity disorder or neu-
rocognitive or immune development [16]. These findings
are in accordance with results from previous studies that
show a high rate of adequately developed children born
to kidney transplanted mothers [13, 14].
The aim of this multi-center study was to evaluate
pregnancies following kidney transplantation and their
impact on mother, graft and fetus/ early childhood with
observation up to 2 years after delivery.
Patients and methods
Study design and population
From January 1st 2002 through 31th December 2016, we
evaluated retrospectively all 28 consecutive patients with
pregnancy and delivery after kidney or simultaneous
kidney-pancreas transplantation at University Hospital
Tuebingen and Charité University Berlin. Only pregnancies
resulting in birth > 23weeks of gestation were included.
Mycophenolate (MPA) was routinely used for rejection
prophylaxis in both centers since 1996. MPA was rou-
tinely discontinued at least 4 weeks prior to planned
pregnancy and replaced by steroids or azathioprine, re-
spectively. The decision to either steroids or azathio-
prine was left at discretion of the treating physician.
After confirmation of pregnancy clinical parameters
were recorded at regular intervals by department of
gynecology and nephrology. The following characteris-
tics were analyzed: age at transplantation/ delivery, kid-
ney function pre- pregnancy/ at one and six months/ at
one year and up to two years after delivery were gath-
ered. Pre-pregnancy creatinine was defined as the latest
result within three months before pregnancy. Glomeru-
lar filtration rate (GFR) was calculated according to the
2009 Chronic Kidney Disease Epidemiology Collabor-
ation (CKD-EPI) equation [17]. Time interval from
transplantation to pregnancy was set to the estimated
date of conception and in case of several pregnancies it
was calculated separately for each pregnancy. Graft loss
after pregnancy was defined as returning to dialysis or
transplantation. We also recorded the following parame-
ters: cause of end-stage renal disease (ESRD), donor type
(living/ deceased donor), type of maintenance immuno-
suppressive therapy, occurrence of pre-pregnancy hyper-
tension (defined as preexisting intake of antihypertensive
treatment or hypertensive blood pressure profiles) and
other complications like new-onset hypertension, pre-
eclampsia (diagnosed according to revised recommenda-
tions of American Congress of Obstetricians and
Gynecologists) [18], gestational diabetes and incidence
of caesarean section. Indications for caesarean deliveries
were subdivided into three categories: maternal, fetal
and combined fetal/maternal. Maternal indications con-
sisted of severe hypertensive disorder in pregnancy, pre-
eclampsia, deterioration of kidney graft function includ-
ing urine retention and increase in proteinuria or amni-
otic fluids disorders, prolonged labor and previous
caesarean delivery. Fetal indications included intrauter-
ine growth restriction, fetal distress like cardiotocogram
abnormalities and fetal malposition; complications re-
lated to both, mother and fetus, such as prolonged labor
and chorioamnionitis. Gestational age was calculated in
weeks starting from the first day of the patient’s last
menstrual period. In presence of an early ultrasound
gestational age as calculated from that.
To determine the association between outcomes and
the interval between kidney transplant and pregnancy,
we defined the following groups: <two years versus two
to five years versus more than 5 years.
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Additionally, physical and psychomotor development
of the children in our cohort up to 2 years were exam-
ined by a pediatrician. Specifically, neonatal outcome
was observed, including birth weight, gestational age,
intrauterine growth restriction, APGAR -score (Appear-
ance, Pulse, Grimace, Activity, Respiration), malforma-
tion. In order to achieve age-related variables, corrected
age based on expected date of birth in preterm deliveries
was used. Data were collected from the patient’s medical
records. Weight was measured with an electronic scale
accurate to the nearest 1 g. Length was measured with
an infant-length board to the nearest 1 mm when the
weight was > 1.000 g or with a nonstretch measuring
tape for very preterm infants in a closed incubator. Head
circumference was measured in the largest frontooccipi-
tal plane to the nearest 1 mm with a nonstretch measur-
ing tape. Weight, length and head circumference were
converted to age-specific and gender-specific Z-scores
according to the WHO growth chart using calculator
(Anthro software).
Additionally, all mothers after live birth were asked to
complete a questionnaire on their childrens’ physical de-
velopmental status. The questionnaire contained phys-
ical examination, anthropometric measures, medical and
paramedical history. These findings were derived from
medical examination by the pediatrician. It was comple-
mented by regular pediatric exams of functions and abil-
ities at 12 and 24 months (± 2months) the results of
which were reported within the questionnaires.
Neonates were categorized according to World Health
Organization defined as extreme premature (< 28 weeks
of gestation), very preterm (28–32 weeks) and moderate-
to-late preterm (32–37 weeks) [19]. They were also cate-
gorized according to their birth weight as defined by
World Health Organization as low birth weight (LBW;
< 2.500 g) regardless of gestational age at time of birth.
Based on gestational age, percentile values for birth
weight, birth length and head circumference for girls
and boys were calculated according to Voigt et al. [20].
Neonatal death was defined as dying within 28 days after
delivery. Based on gestational age-adjusted birth weight,
birth length or head circumference, percentiles are cal-
culated for infants classed as small for gestational age
(SGA), appropriate for gestational age (AGA, 10th –
90th percentile) or large for gestational age (LGA). A
birth weight < 10th percentile is described as SGA; a
birth weight > 90th percentile is described as LGA. Fetal
growth restriction (FGR) is defined as growth <10th per-
centile and pathologic doppler- ultrasound of umbilical
artery or uterine artery.
Statistics
Data are reported as mean (standard deviation) or me-
dian [interquartile range (IQR)] for skewed data. All
statistical analyses were performed using SPSS version
25 (SPSS Inc., Chicago, IL, USA). Continuous variables
were compared using Student t-test. Graft and patient
survival were analyzed by Kaplan-Meier analysis. Values
of p < 0.05 were considered as statistically significant.
Results
Over the 14-year period 28 women had 32 pregnancies
(> 23 gestational weeks) resulting in 32 live births, in-
cluding five women (17.8%) who had two live births.
Maternal characteristics
26 women had received only a kidney transplant; two
women a simultaneous kidney-pancreas transplantation.
Table 1 summarizes the baseline maternal characteris-
tics. Twenty-three patients were recipients of a first kid-
ney transplant, two of a second transplant, and one
patient got a third transplant. Almost 50% of patients
(12/28, 46.1%) were recipients of living related donor
Table 1 Maternal characteristics of kidney transplant recipients
with pregnancy
Patients n = 28(%)*
Age at transplantation (years) 26.4 ± 5.6
Age at delivery (years) 32.0 ± 4.3
Number of kidney transplantations
1st kidney transplant 23(82.2)
2nd kidney transplant 2(7.1)
3rd kidney transplant 1(3.6)
Kidney-pancreas transplant 2(7.1)
Living kidney donor 12(46.1)
Deceased donor 16(53.9)
Cause of end-stage renal disease
Glomerulonephritis 11(39.3)
Diabetes type I 2(7.1)






Interval from transplantation to conception**
< 2 years 2(6.1%)
2–5 years 9(27.2%)
≥ 5 years 21(65.6%)
Pre-pregnancy hypertension 19(67.8)
Number of antihypertensive agents pre-pregnancy, median 2
*26 renal transplanted women and two simultaneous kidney-pancreas
transplanted women
**five patients had two pregnancies. Each pregnancy was
calculated separately
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kidney transplant (Table 1). The most common primary
maternal diagnosis was chronic glomerulonephritis (11/
28, 39.2%). Age at transplantation was 26.3 years in me-
dian (IQR 22.3, 29.9) and 32.8 years (IQR 29.3, 35.3) at
delivery. Pregnancies occurred at a median of 5.9 years
(IQR 3.3, 8.6) after transplantation, 65.6% of pregnancies
occurred > 5 years after transplantation. Hypertension
was present in 67.8% of women before pregnancy. Im-
munosuppressive regimens for the 32 pregnancies are
shown in Fig. 1. Maintenance immunosuppression con-
sisted of calcineurin-inhibitor (tacrolimus (n = 20) or
Cyclosporine A (n = 6)) and steroids as dual therapy in
majority of pregnancies (26/32, 81.2%). Three women re-
ceived triple immunosuppression in combination with
azathioprine (Fig. 1). One woman received azathioprine
monotherapy and two were on monotherapy with tacro-
limus (Fig. 1). In the majority of the women (89.3%)
MPA was stopped prior to planned pregnancy and in
three women (10.7%) after confirming pregnancy.
Most of the pregnancies occurred more than 5 years
after transplantation (Tables 1,2).
The comparison of interval between > 2-5 years
and > 5 years from transplantation to pregnancy leads
to following results (Table 2).
The gestational age median was 36.29 weeks in pa-
tients at two to five years interval after transplantation
vs 34.29 weeks in patients > 5 years after transplantation.
The highest rate of preterm birth occurred in the inter-
val between transplantation and pregnancy > 5 years asso-
ciated with low birth weight in 80.9% (Table 2) without
significant difference. A significantly higher rate of pre-
eclampsia was seen in the group > 5 years compared to
the group > 2-5 years (n = 5; p = 0.021; Table 2). None of
the patients in the group > 2-5 years had preeclampsia.
Duration of gestations and delivery mode
Duration of all 32 enrolled pregnancies was 34.7 gesta-
tional weeks in median (IQR 31.9, 36.3, Table 3). 78.2%
of children (n = 25) were born prematurely, thereof four
(12.5%) were born < 28 weeks because of maternal infec-
tion or early contractions (Table 4). In 24/32 pregnan-
cies (75%) a caesarean section was performed, thereof
two patients received a caesarean section with labor; 8
patients (25%) had a vaginal delivery (Table 3). Six pa-
tients had already undergone caesarean section before
transplantation. Most often (66.7%), primary caesarean
section was performed due to maternal conditions, in 5
(20.8%) patients due to fetal conditions and in 3 (12.5%)
patients due to combined fetal/maternal conditions
(Table 3). Of those patients with primary caesarean due
to maternal conditions 5 patients (20.8%) had pre-
eclampsia. One of those developed aortic dissection due
to worsening of hypertension and an emergent caesarean
section was performed in the 30th gestational weeks. For
those in the fetal/maternal indication category one had
placental abruption and two had placental insufficien-
cies; FGR and fetal distress during labor were fetal indi-
cations for caesarean in 5 cases (Table 3). No graft
injuries occurred during delivery.
Maternal complications in gestation
Five women (20.8%) developed preeclampsia resulting in
caesarean section at a minimum of 262/7, 294/7, 323/7,
344/7 and 350/7 gestational weeks, respectively (Table 3).
Gestational diabetes was detected in 2 cases (6.2%, Table 3).
Interestingly, none of the patients after living donor trans-
plantation presented with gestational hypertension, pre-
eclampsia or gestational diabetes (data not shown). There
was no case of maternal death in the cohort during
Fig. 1 Immunosuppressive regimens during pregnancy
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pregnancy or within the first two years postpartum. In six
women declining in kidney function and in two worsening
of proteinuria were causes for delivery.
Graft outcome
Creatinine before pregnancy was 1.2 mg/dl in median
(range 0.6–3.1) and GFR (CKD-EPI) 57 ml/min/1.73m
2 in
median (IQR 52, 75 ml/min/1.73m2), respectively
(Table 3). At delivery, GFR(CKD-EPI) was significantly
lower ((49 ml/min/1.73m2), IQR 37, 59 ml/min/1.73m2,
p = .005) compared to pre-pregnancy values (Table 3;
Fig. 2). Out of these patients, in 13 patients (46.4%) loss
of GFR at delivery compared to pre-pregnancy values
was more than 10 ml/min. Whereas, in 19 patients the
loss of GFR was < 10ml/min compared to pre-pregnancy
values. At 6months after delivery median GFR (CKD-EPI)
was 48ml/min/1.73m2 (IQR 37, 60ml/min/1.73m2). One
year after delivery and at last follow-up median GFR




(n = 9) (%)
> 5 years
(n = 21) (%)
P value
Median maternal age at delivery (years, IQR) 32.8(29.5, 33.5) 32.9(29.0, 36.0) 0.533
Preeclampsia 0 5(23.8%) 0.021
Caesarean section 5(55.5%) 18(85.7%) 0.075
Preterm birth 5(55.5%) 17(80.9%) 0.078
Gestational age
(weeks), Median (IQR)
36.29 (34.7, 37.5) 34.3 (29.6, 36.1) 0.030
Birth weight (g)
Median (IQR)
2.280(1.940, 2715) 1.885(985, 2290) 0.058
Low birth weight 5(55.5%) 17(80.9%) 0.078
Evaluation of 32 pregnancies (thereof 5 patients with 2 pregnancies) subdivided in 2 groups according to transplant interval. Values are presented as median
(interquartile range, IQR)
Table 3 Pregnancy outcome until 2 years after delivery
Patients n = 28
Number of pregnancies 32
Median gestational age (weeks), IQR 34.7(31.9, 36.3)
Delivery
Vaginal birth 8(25%)
Caesarean section without labor* 22(68.8%)
Caesarean section with labor 2(6.2%)
Preeclampsia 5(15.6%)
Gestational diabetes 2(6.2%)
Indication for caesarean section
Maternal 16(66.7%)
Fetal 5(20.8%)
Combined (maternal and fetal) 3(12.5%)
Renal outcome
Pre-pregnancy GFR (CKD-EPI) (ml/min/1,73m
2), median (IQR) 57(52, 78)
GFR (CKD-EPI) at delivery 49(37, 59)
a
GFR (CKD-EPI) 12 months after delivery 50(39, 69)
b
GFR (CKD-EPI) 24 months after delivery 47(41, 80)
Graft failure within 24 months after delivery 2(6.2%)
Proteinuria
Proteinuria at delivery, mg/g creatinine, median (range) 335(100–4000)
All 32 pregnancies resulting in life births are evaluated. The indication for caesarean section is evaluated in 24 pregnancies and is subdivided in three groups
(maternal/ fetal/ combined maternal and fetal). GFR, glomerular filtration rate. IQR, interquartile range
*two emergency caesarean section due to aortic dissection due to severe hypertensive disorder and major placental abruption
eGFR (CKD-EPI), estimated glomerular filtration rate.
aP 0.005 and bP 0.001 versus GFR (CKD-EPI) at pre-pregnancy
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(CKD-EPI) remained lower compared to pre-pregnancy
levels 50ml/min/1.73m2 (IQR 39, 69ml/min/1.73m2).
GFR (CKD-EPI) at 24months after delivery was lower than
the all other GFR (CKD-EPI) values at delivery, and at 12
months after delivery there was no significant difference
(Table 3). Proteinuria at delivery was in median 335mg/g
creatinine (Table 3).
Two graft losses were observed within one year after
delivery, that occurred at intervals of one and 12 months,
respectively (Table 3). Resulting in 92.8% 2 year graft
survival after delivery. One patient had already poor kid-
ney function before pregnancy with low GFR (CKD-EPI) of
approximately 17 ml/min. This patient experienced graft
loss at one month after delivery corresponding to 9.3
years after transplantation. The kidney biopsy showed
severe interstitial fibrosis, tubular atrophy and severe
vascular damage. 14 months later she received a second
transplant from her mother. The other patient experi-
enced graft loss 12 months after delivery (6.1 years after
transplantation), resulting in chronic graft nephropathy
and thrombotic microangiopathy in the kidney biopsy.
Two patients after kidney-pancreas transplantation de-
livered three babies. They were delivered by caesarean sec-
tion due to FGR at 304/7, 322/7 and 340/7 weeks of
gestational age, respectively. Both, pancreas and kidney
graft function were stable during pregnancy and at the
follow-ups 13, 90 and 139months after delivery and at 85
and 163months after kidney-pancreas transplantation.
Overall, GFR (CKD-EPI) at two years was still worse than at
date of delivery with lowest values collected at 6months.
Table 4 Characteristics of newborn
Live births n = 32(%) P value
Median gestational age (weeks), (IQR) 34.7(31.9, 36.3)
Live births (gestational age, weeks)
Extremely premature birth (< 28 weeks) 4(12.5)
Very premature birth (28–32 weeks) 4(12.5)
Moderate- to late premature birth (32–37 weeks) 17(53.1)
Term > 37 7(21.8)






< 2500 g, low birth weight* 25(75.7)
Median birth weight (grams, IQR) 0.002
Preterm 1810(1105, 2240)
Term 2550(2225, 2915)
Median Birth length (cm, IQR) 0.006
Preterm 43.0(37.0, 46.0)
Term 48.0(46.0, 50.0)
Head circumference (cm, IQR) 0.011
Preterm 31.0(27, 32.5)
Term 33.0(32.0, 34.0)
pH at delivery (livebirths)
< 7.0 0
> 7.0-≤ 7.1 1(3.1)
> 7.1-≤ 7.2 8(25)
> 7.2 23(71.8)
APGAR
≤ 4 after 1 min 5(15)
< 7 after 5 min 7(21.2)
All live birth were analyzed, n = 32. SGA: small for gestational age, AGA: adequate for gestational age
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Fetal outcome and development
The majority of the children (n = 25) were born prema-
turely (78.2%) and the gestational age was 34.7 weeks in
median (IQR 31.9, 36.3 weeks; Table 4, Fig. 3). Reasons
for preterm delivery were as follows: thereof 16 were
caused by maternal indications, nine with contractions/
bleeding and seven with deterioration of graft function.
Six patients had preterm delivery based on fetal indica-
tions: thereof four patients caused by pathological fetal
heart rate and two patients due to growth arrest in
Fig. 3 Birthweight and gestational age
Fig. 2 Kidney function during pregnancy and follow-up
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combination with FGR. Three patients had preterm deliv-
ery based on combined fetal and maternal indications with
pathological fetal heart rate pattern and contractions/
bleeding. Most often moderate-to-late premature babies
(320/7–366/7 gestational weeks) was accounted for 53.1%
of births; 21.8% were born > 37 gestational weeks. Charac-
teristics of children are shown in Table 4. One baby died
on the first day of his life due to extreme prematurity
(235/7 weeks). Birth weight was 2.030 g in median (IQR
1380 g, 2375 g; Table 3). The majority of children (75.7%)
had low birth weights (< 2.500 g) (Table 4, Fig. 3).
The majority of children (71.8%) had a cord blood gas
within a normal pH (> 7.2) range (Table 4). 25% had a pH
between 7.1 and 7.2 (Table 4). Only 7/32 (21.1%) children
had a low Apgar score < 7 five minutes after birth. Weight,
length and head circumference at birth is shown subdi-
vided in term and preterm delivery in Table 4.
Childrens development from birth through age of 2 years
Response rate´ was 92.8%.
Evaluation of anthropometric measures 12 and 24
months after birth, subdivided in preterm and term at
delivery, is shown in Table 5. Analysis of weight, length
and head circumference was performed on children with
an existing follow up of 24 months. Finally, 65.6% of
children had complete dataset at 24 months (Table 5,
Table 6). At birth significant differences were detected
between the term and preterm group for weight/ length
and head circumference (Table 5). 12 months after birth
the differences in groups for weight/ length and head
circumference had decreased and made no further sig-
nificant difference (Table 5).
Differences tended to decrease after 12 and even 24
months of age in mean weight-for age, length-for-age
and head circumference-for-age z-score (Table 6,
Fig. 4a-c); at that time results have no significant
difference between both groups regarding anthropomet-
ric data (Fig. 5).
The following abnormalities were observed at birth:
microcephaly, microsomia and cryptorchism in one
child and one child presented with strabism and
bronchial asthma. The physical exam was normal in
93.75% (30/32) at 12 months and in 95.2% (20/21) at
24 months. In two very prematurely born children,
mild neurological deviations were noted at one year
of age, muscle tone disturbances in lower limbs and
slightly reduced muscle tone in lower limbs, respect-
ively. The respective findings had decreased in sever-
ity at 24 months of age. Noteworthy, their deficiencies
were clearly found to have improved after two years
of age. This was documented in the children’s med-
ical records and was confirmed by neurological
examination.
Table 5 Anthropometric measures at birth, at 12 and at 24 months of age in preterm and term born babies
Parameter Preterm Term P value
Birth (median, IQR),
Weight, g 1.810(1105, 2240) 2.550(2225, 2915) 0.002
Length,cm 43.0(37.0, 46.0) 48.0(46.0, 50.0) 0.006
Head circumference, cm 31.0(27, 32.5) 33(32.0, 34.0) 0.011
12 months (median, IQR),
weight, g 8760(7670, 9570) 9180(9090, 9992) 0.704
length, cm 74.0(72.0, 75.5) 74.1(73.3, 76.3) 0.71
Head circumference, cm 46.0(45.0, 46.7) 46.0(46.0, 49.0) 0.365
24 months, (median, IQR)
weight, g 11.800(10.950, 13.250) 11.900 (11.600, 12.900) 0.769
length, cm 84.0(83.0, 87.7) 86.0(84.5, 88.3) 0.308
Head circumference, cm 48.2 (47.5, 49.5) 49.5(48.5, 49.7) 0.410
Preterm less than 37 gestational weeks, Term ≥37 gestational weeks until 42 gestational weeks. Values are presented as median and interquartile range
Table 6 Weight-for-age, length-for-age and head




12 months −0.375(−0.82, 0.1)
24 months −0.31(−0.94, 0.32)
Length (IQR)
Birth −.79(− 1.43, − 0.15)
12 months − 0.07(− 0.69, 0.28)
24 months −0.78(− 1.15, − 0.17)
Head circumference (IQR)
Birth −.65 (− 1.4, 0.0075)
12 months − 0.28(− 0.74, 0.51)
24 months −0.05(− 1.1, 0.36)
Values are presented as median and interquartile range
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Discussion
It is well recognized that risk of maternal and neonatal
pregnancy-related complications in women having under-
gone kidney transplant is significantly increased when com-
pared to general population [7]. Our study in 28 recipients
confirms the high rates of obstetric complications in women
following transplantation. To elucidate the developmental
perspective of their children rather than to merely list and
describe maternal factors, we further investigated the mid-
term outcomes that were assessed by the pediatrician and
were supplemented by a questionnaire sent out to parents.
Taken together, outcome and development of children was
found to be encouraging even though initial incidences of
prematurity and low birthweight initially were substantial.
Fig. 4 a-c Z score weight (a), head circumference (b), length (c)
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In our series, prematurity rate of 78% was higher com-
pared to previous reports with incidences between 45 and
56% [2–5, 7] and especially when compared to a preterm
delivery rate in the general population in Germany in
2016 with 8.6%. However, only one out of 32 infants
analyzed died due to complications from extreme prema-
turity. Of note, predominantly moderate-to-late prema-
ture (320/7–366/7 gestational weeks) births were observed
due to acute pregnancy-related causes such as acute pla-
cental insufficiency, severe preeclampsia, intrauterine
Fig. 5 Anthropometric data. Development of children at 12 and 24 months of age. Values are overlapped onto the 3rd, 50th and 97th percentiles
of the World Health Organization Child Growth Standards, girls lines in pink and boys blue lines. For preterm born children adjusted for
calculated birth date was used
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growth restriction with abnormal fetal heart rate tracing,
infections like chorioamnionitis or deteriorating kidney
graft function.
Generally, preterm children, even if being late preterm
(340/7–366/7gestational weeks) are at a higher risk for
mortality and impaired neurodevelopmental outcomes
such as cerebral palsy, mental retardation as well as
more behavioral abnormalities than term-born children
[21]. Therefore, it is of crucial importance to avoid even
non-spontaneous late preterm birth to reduce not only
immediate neonatal but also complications at later age.
This necessitates consistent therapy of existing and de-
fined risk factors. As recently reported, renal allograft re-
cipients have a 13-fold higher risk of preterm deliveries
and also a 5-fold high risk for small-for-gestation babies
compared to the general population [22].
Birth weight was significantly lower in preterm com-
pared to term-born babies. Nevertheless, despite a high
rate of small-for-gestational age (31.5%) infants in our
series, at 12 and 24months all children had both adequate
weight and height for age. This confirms results from a
first large prospective controlled study in children born to
transplant recipients [23] but is in stark contrast to an-
other study examining children only at a median of eight
years [24]. This suggests that retardation might still occur
years after a seemingly normal development.
In our study, we acquired data until the age of two
years, when the weight and height as well as head cir-
cumference differences compared to general population
had decreased over time. Only one child was still small for
age (Fig. 4a-c). We observed only in two very prematurely
born children, mild neurological deviations at one year of
age. The respective findings had decreased in severity at 2
years of age which is consistent with another report [23].
Interestingly, Nulman and coworkers found no differences
in neurocognitive nor behavioral outcomes between eight
year-old children exposed to cyclosporine in utero versus
age-matched controls from healthy mothers [24]. In light
of these findings it is difficult to make recommendations
for general population about neurological outcomes at the
age of 12months due to the small sample size and the
retrospective design.
In accordance to the report of Sibanda et al. [3], the rate
of caesarean deliveries in this study was as high as 73.5%
due to worsening of hypertensive disorders/ preeclampsia
and deteriorating in kidney function while in the back-
ground population, 30.5% of all pregnant women in
Germany deliver by caesarean section [18]. However, prog-
nosis for mothers and children is nevertheless favourable.
Optimal timing might affect the outcomes of preg-
nancy, the maternal graft function and maternal comor-
bidities. We could show that premature birth rate, low
birth weight and caesarean section rate were lower in
the current study in pregnancies between two and five
years after transplantation. A recent retrospective study
of 729 pregnancies revealed an increased risk of graft
loss during the first and second year after transplant-
ation whereas pregnancy in the third year was no longer
associated with an increased graft failure rate [25]. In ac-
cordance to our data, Mohammadi and coworkers
showed that one-third of patients had deterioration in
graft function during pregnancy and of those 63.2% did
not return to baseline [8].
It still needs to be confirmed, whether our data sug-
gesting increasing incidences of prematurity, low birth-
weight, caesarean section and preeclampsia in the group
of women with an interval of > five years from trans-
plant can be generalized. Interestingly, a recent report
showed a high rate of preeclampsia but no association
with long-term renal dysfunction [26].
In our analysis childrens´ development was followed
up to the age of two years. However due to prolonged in
utero exposure to a large variety of immunosuppres-
sants, adverse effects occurring much later cannot be
fully excluded. Specifically, cardiovascular and renal dis-
ease might be of importance [27, 28]. To gain more
insight, children born to mothers receiving immunosup-
pression for other reasons than transplant could be
followed to increase cohort size [29].
Taken together, in this complicated situation with
multiple underlying factors affecting maternal and fetal
outcome these data indicate an encouraging outcome
provided that strict controls in close intervals be per-
formed. The impact of sustained deterioration of kidney
function following pregnancy requires further research.
Conclusion
Pregnancies following kidney or kidney-pancreas trans-
plantation are associated with a significant rate of pre-
maturity and low birth weight babies and should
therefore be considered as “high risk”. Development of
the children up to 2 years after birth was found to be
good and age-appropriate in our study. Affected women
should be managed in tertiary care obstetrics centers
working in a tight multidisciplinary cooperation with
transplant physicians, i.e. nephrologists, diabetologists,
and neonatologists. We are currently setting up a na-
tionwide registry for pregnancy following solid organ
transplantation to prospectively evaluate future cases.
This may help to improve performance and outcome of
both mother and their children.
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